WDR82 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.771200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.154600E-01
Normal-vs-Stage2
2.960400E-01
Normal-vs-Stage3
2.786300E-02
Normal-vs-Stage4
8.063000E-01
Stage1-vs-Stage2
8.104800E-01
Stage1-vs-Stage3
4.964400E-02
Stage1-vs-Stage4
2.356400E-01
Stage2-vs-Stage3
7.225800E-02
Stage2-vs-Stage4
1.218650E-01
Stage3-vs-Stage4
1.198010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.629400E-01
Normal-vs-AfricanAmerican
8.357000E-01
Normal-vs-Asian
1.045220E-01
Caucasian-vs-AfricanAmerican
2.883800E-01
Caucasian-vs-Asian
1.588360E-01
AfricanAmerican-vs-Asian
1.488640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.713400E-01
Normal-vs-Female
3.014000E-01
Male-vs-Female
5.350800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.880400E-01
Normal-vs-Age(41-60Yrs)
5.275400E-01
Normal-vs-Age(61-80Yrs)
2.285200E-01
Normal-vs-Age(81-100Yrs)
5.556000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.587400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.711400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.019400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.345700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.794000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.691600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.814500E-02
Normal-vs-Daily Drinker
1.491620E-01
Normal-vs-Weekly Drinker
2.730600E-01
Normal-vs-Occasional Drinker
2.872800E-01
Normal-vs-Social Drinker
5.739000E-01
Non Drinker-vs-Daily Drinker
6.434000E-01
Non Drinker-vs-Weekly Drinker
3.305200E-01
Non Drinker-vs-Occasional Drinker
1.928810E-01
Non Drinker-vs-Social Drinker
9.195600E-02
Daily Drinker-vs-Weekly Drinker
5.894800E-01
Daily Drinker-vs-Occasional Drinker
4.180000E-01
Daily Drinker-vs-Social Drinker
2.216000E-01
Weekly Drinker-vs-Occasional Drinker
8.454200E-01
Weekly Drinker-vs-Social Drinker
5.221000E-01
Occasional Drinker-vs-Social Drinker
5.952600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.593000E-01
Normal-vs-Grade 2
7.413900E-02
Normal-vs-Grade 3
9.112300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.556640E-01
Grade 1-vs-Grade 3
3.523200E-01
Grade 1-vs-Grade 4
2.593000E-01
Grade 2-vs-Grade 3
6.321400E-01
Grade 2-vs-Grade 4
7.413900E-02
Grade 3-vs-Grade 4
9.112300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.867600E-01
Normal-vs-NonDiabetic
1.523420E-01
Diabetic-vs-NonDiabetic
8.412800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.449350E-01
Normal-vs-NoPancreatitis
2.190000E-01
Pancreatitis-vs-NoPancreatitis
7.177400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.172800E-01
Normal-vs-N1
2.879400E-01
N0-vs-N1
7.531000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.667000E-01
Normal-vs-TP53-NonMutant
4.997400E-01
TP53-Mutant-vs-TP53-NonMutant
7.895400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
